EUVIMEDEUVIMED entdecken
Crossref

Genetic Profile of FOXO3 Single-Nucleotide Polymorphism in Colorectal Cancer Patients

Laraib Uroog, Arshad Husain Rahmani, Mohammed A Alsahli, Saleh A Almatroodi, Rauf Ahmad Wani, M Moshahid Alam Rizvi

Oncology · 2024

DOI: 10.1159/000533729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Laraib Uroog und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Genome Biology Lab, Jamia Millia Islamia, New Delhi, India. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Colorectal cancer (CRC) heritability is determined by the composite relations between inherited variants and environmental factors. In developing countries like India, the incidence rates of CRC are especially increasing. In this study, we have focused on the distribution of the FOXO3 gene polymorphisms among the patients with CRC in North India.

Methods

A case-control study was conducted on 487 CRC patients and 487 age-matched controls. We genotyped single-nucleotide polymorphisms rs2253310 and rs4946936 through polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis and PCR-single-stranded conformation polymorphism procedure followed by sequence detection.

Results

A significantly increased risk of CRC was observed for the CC genotype of the rs4946936 polymorphism compared to the TT genotype (p = 0.02; odd ratio [OR] = 1.40, confidence interval [CI] = 1.05–1.87). GT haplotype appeared to be a “risk” haplotype (OR = 1.71, 95% CI = 0.82–2.19), while as other haplotypes CC (OR = 0.83, 95% CI = 0.32–1.54), CT (OR = 0.75, 95% CI = 0.25–1.01), and GC (OR = 0.98, 95% CI = 0.88–1.14) were found to be “protective” for developing CRC.

Conclusion

This study suggests an association of increased risk of CRC with the rs4946936 polymorphism but not with the rs2253310 polymorphism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseColorectal NeoplasmsHumansPolymorphism, Single NucleotideCase-Control StudiesGenetic ProfileGenotypeForkhead Box Protein O3

Stichwörter der Autor:innen

Colorectal cancerFOXO3 geneSingle-nucleotide polymorphismrs2253310rs4946936

Substanzen

FOXO3 protein, humanForkhead Box Protein O3

Autor:innen und Institutionen

  • Department of Biosciences, Genome Biology Lab, Jamia Millia Islamia, New Delhi, India.
  • Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
  • Department of General Surgery, SKIMS, Srinagar, India.

Zitieren

APA

Uroog, L., Rahmani, A. H., Alsahli, M. A., Almatroodi, S. A., Wani, R. A., & Rizvi, M. M. A. (2024). Genetic Profile of FOXO3 Single-Nucleotide Polymorphism in Colorectal Cancer Patients. Oncology. https://doi.org/10.1159/000533729

Vancouver

Uroog L, Rahmani AH, Alsahli MA, Almatroodi SA, Wani RA, Rizvi MMA. Genetic Profile of FOXO3 Single-Nucleotide Polymorphism in Colorectal Cancer Patients. Oncology. 2024. doi:10.1159/000533729

BibTeX
@article{Uroog2024,
  author = {Uroog, Laraib and Rahmani, Arshad Husain and Alsahli, Mohammed A and Almatroodi, Saleh A and Wani, Rauf Ahmad and Rizvi, M Moshahid Alam},
  title = {Genetic Profile of FOXO3 Single-Nucleotide Polymorphism in Colorectal Cancer Patients},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000533729}
}
Kostenlos starten →